| 000 | 01615 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513093233.0 | ||
| 264 | 0 | _c19960909 | |
| 008 | 199609s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/BF00195933 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcElnay, J C | |
| 245 | 0 | 0 |
_aA pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _c1996 |
||
| 300 |
_a471-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Sublingual |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCaptopril _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhosphates _xmetabolism |
| 650 | 0 | 4 |
_aPotassium Compounds _xmetabolism |
| 650 | 0 | 4 |
_aRenin _xblood |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 700 | 1 | _aal-Furaih, T A | |
| 700 | 1 | _aHughes, C M | |
| 700 | 1 | _aScott, M G | |
| 700 | 1 | _aNicholls, D P | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 49 _gno. 6 _gp. 471-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00195933 _zAvailable from publisher's website |
| 999 |
_c8704015 _d8704015 |
||